Consensus statement on depression, anxiety, and cardiovascular disease.
Ballenger
J C
JC
Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences, Charleston 29425-0742, USA.
Davidson
J R
JR
Lecrubier
Y
Y
Nutt
D J
DJ
Roose
S P
SP
Sheps
D S
DS
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D015928:Cognitive Behavioral Therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D017410:Practice Guidelines as Topic; D013811:Psychotherapeutic Processes; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D017367:Selective Serotonin Reuptake Inhibitors